VAI-SU2C Epigenetics Dream Team
36 results.
VARI-affiliated cancer researcher Stephen Baylin, M.D., has been elected to the National Academy of Sciences…
Safety and efficacy of combining talazoparib with decitabine to treat acute myeloid leukemia (AML) are subject of multi-site clinical trial
GRAND RAPIDS, Mich. (March 7,…
March marks Colorectal Cancer Awareness Month, a time to share information and raise awareness about these devastating diseases. Here are three key…
When it comes to biomedical research and science education, a year can make all the difference. In 2016, we celebrated Van Andel…
What happens when scientists collaborate rather than compete? In this case, the result is a combination of two drugs that may be a more effective…
Last Friday, Stand Up To Cancer (SU2C) hosted its fifth live telecast, which brought together top scientists, actors and musicians in support of cancer research.…
EDITOR’S NOTE: Maintaining proper nutrition is an important part of cancer therapy. Patients are urged to consult their doctors before making any change to their…
Note: This press release was written by Stand Up To Cancer (SU2C). Van Andel Research Institute (VARI) is home to the VARI-SU2C Epigenetics Dream…